How to appeal a Humana sickle cell & thalassemia denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for sickle cell & thalassemia

Cited policy: Humana MA — defers to CMS NCD 110.23 + CED for gene therapies

CMS NCD 110.23 + CED registry enrollment. ATC must be CMS-approved.

How Humana denies sickle cell & thalassemia — and how to counter it

Where Humana pushes back: 1) ATC not CMS-approved; 2) CED registry not confirmed; 3) ICD-10 specificity issues.

Counter-arguments that hold up: CMS registry enrollment ID. Precise ICD-10 (D57.1 HbSS, D57.2 HbSC, D57.40-D57.219 with crisis subtypes, D56.1 beta-thal major). NCD 110.23 + CED citation verbatim.

What Humana typically denies for sickle cell & thalassemia

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For sickle cell & thalassemia, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the sickle cell & thalassemia treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Casgevy
• Lyfgenia
• Zynteglo
• Allogeneic HSCT
• Hydroxyurea
• Adakveo

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.